Influence of the PPAR-γ2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects

被引:33
作者
Ostergård, T
Ek, J
Hamid, Y
Saltin, B
Pedersen, OB
Hansen, T
Schmitz, O
机构
[1] Aarhus Univ Hosp, Aarhus Sygehus, Dept Med Endocrinol & Diabet M, DK-8000 Aarhus, Denmark
[2] Univ Aarhus, Dept Clin Pharmacol, Aarhus, Denmark
[3] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[4] Hagedorn Res Inst, DK-2820 Gentofte, Denmark
[5] Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark
关键词
polymorphism; type; 2; diabetes; exercise; insulin resistance;
D O I
10.1055/s-2005-861174
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aerobic endurance training improves insulin sensitivity, and is of great importance in the prevention and treatment of type 2 diabetes. The improvement in insulin sensitivity and cardiovascular function through exercise is highly variable among individuals, and is probably partly determined by genetic components. This study evaluated the peroxisome proliferation-activated receptor-gamma 2 (PPAR-gamma 2) Pro12Ala polymorphism and the angiotensin converting enzyme (ACE) I/D polymorphism with respect to any potential influence that these highly prevalent polymorphisms may impose on changes in insulin sensitivity and maximal aerobic capacity induced by exercise. Seventy-nine healthy first-degree relatives of type 2 diabetic patients were compared to a control group consisting of 54 subjects without any family history of type 2 diabetes. All subjects had a normal OGTT. The groups were comparable with respect to age (34 +/- 7 vs. 33 +/- 7 years), gender ((m/f) 43/36 vs. 30/24) and BMI (25.7 +/- 2.6 vs. 25.3 +/- 2.5 kg/m(2)); p (all) = NS. Furthermore, a subgroup of 29 offspring and 17 controt subjects were engaged in a standardized training program lasting ten weeks. Insulin sensitivity (hyperinsulinemic euglycemic clamp technique) and VO(2)max (exhaustive exercise test) was assessed before and after the training period. We will demonstrate the allelic frequency of the Ala-allele of the Pro12Ala polymorphism to be lower in offspring to type 2 diabetic patients (13.3%) compared to control subjects (21.3%); p < 0.05. In offspring only, the Pro12Ala polymorphism of the PPAR-gamma 2 gene appeared to enhance weight changes brought about by exercise (Delta weight = -0.3 +/- 1.4 kg vs. - 1.8 +/- 1.8 kg; p < 0.05; (Pro/Pro vs. Pro/Ala + Ala/Ala) - suggesting possible gene-environment or gene-gene interactions. The ACE I/D polymorphism was not of significant importance in determining the capability of responding to exercise in terms of improvement in insulin sensitivity or maximal aerobic capacity.
引用
收藏
页码:99 / 105
页数:7
相关论文
共 50 条
[41]   The in vivo effects of the Pro12Ala PPARγ2 polymorphism on adipose tissue NEFA metabolism:: the first use of the Oxford Biobank [J].
Tan, GD ;
Neville, MJ ;
Liverani, E ;
Humphreys, SM ;
Currie, JM ;
Dennis, L ;
Fielding, BA ;
Karpe, F .
DIABETOLOGIA, 2006, 49 (01) :158-168
[42]   Association of PPARG Gene Polymorphisms Pro12Ala with Type 2 Diabetes Mellitus: A Meta-analysis [J].
Li, Junyan ;
Niu, Xiaohong ;
Li, JianBo ;
Wang, Qingzhong .
CURRENT DIABETES REVIEWS, 2019, 15 (04) :277-283
[43]   The influence of the Pro12Ala mutation of the PPAR-gamma receptor gene on metabolic and clinical characteristics in treatment-naive patients with type 2 diabetes [J].
Ahluwalia, M ;
Evans, M ;
Morris, K ;
Currie, C ;
Davies, S ;
Rees, A ;
Thomas, A .
DIABETES OBESITY & METABOLISM, 2002, 4 (06) :376-378
[44]   Cardiovascular risk factors related to the PPARγ Pro12Ala polymorphism in patients with type 2 diabetes are gender dependent [J].
Franck, Niclas ;
Lanne, Toste ;
Astrand, Olov ;
Engvall, Jan ;
Lindstrom, Torbjorn ;
Ostgren, Carl Johan ;
Nystrom, Fredrik H. .
BLOOD PRESSURE, 2012, 21 (02) :122-127
[45]   Polymorphism of Pro12Ala in the Peroxisome Proliferator-Activated Receptor γ2 Gene in Iranian Diabetic and Obese Subjects [J].
Mirzaei, Hassan ;
Akrami, Seyed Mohammad ;
Golmohammadi, Taghi ;
Doosti, Mahmood ;
Heshmat, Ramin ;
Nakhjavani, Manouchehr ;
Amiri, Parvin .
METABOLIC SYNDROME AND RELATED DISORDERS, 2009, 7 (05) :453-458
[46]   The peroxisome proliferator activated receptorγ2 (PPARγ2) Pro12Ala variant:: lack of association with type 2 diabetes in obese and non obese Tunisian patients [J].
Bouassida, KZ ;
Chouchane, L ;
Jellouli, K ;
Chérif, S ;
Haddad, S ;
Gabbouj, S ;
Danguir, J .
DIABETES & METABOLISM, 2005, 31 (02) :119-123
[47]   The Pro12Ala polymorphism of the PPAR-γ2 gene affects associations of fish intake and marine n−3 fatty acids with glucose metabolism [J].
S K Ylönen ;
I Salminen ;
V Lyssenko ;
S M Virtanen ;
L Groop ;
A Aro ;
C Saloranta .
European Journal of Clinical Nutrition, 2008, 62 :1432-1439
[48]   The Pro12Ala polymorphism of PPARγ2 modulates beta cell function and failure to oral glucose-lowering drugs in patients with type 2 diabetes [J].
Masulli, Maria ;
Della Pepa, Giuseppe ;
Cocozza, Sara ;
Capasso, Mario ;
Pignataro, Piero ;
Vitale, Marilena ;
Gastaldelli, Amalia ;
Russo, Marco ;
Dolce, Pasquale ;
Riccardi, Gabriele ;
Rivellese, Angela A. ;
Vaccaro, Olga .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (03)
[49]   The Pro12Ala PPARγ2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men [J].
Rosmond, R ;
Chagnon, M ;
Bouchard, C .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2003, 19 (02) :159-163
[50]   Common polymorphisms of the PPAR-γ2 (Pro12Ala) and PGC-1α (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial [J].
L. Andrulionytè ;
J. Zacharova ;
J.-L. Chiasson ;
M. Laakso .
Diabetologia, 2004, 47 :2176-2184